The detection of protein biomarkers presenting at low concentrations in biological fluids is essential for disease diagnosis and therapeutic monitoring. While magnetic beads-based solid-phase immunoassays have shown promise in achieving high sensitivity for detecting low-abundance proteins. existing protocols suffer from limitations such as the cumbersome need for bead blocking and wa... https://www.jmannino.com/